- Subjects between 18 and 66 years of age.
- Subjects previously enrolled in study A7281009 (NCT01620255) who have completed the
84 day (12 week) induction period.
- Subjects that have completed Day 84 (Week 12) of study A7281009 but have experienced
serious event(s) related to the investigational product, an unstable medical
condition, or any other reason, in the opinion of the investigator, would preclude
entry or participation in this study.
- Subjects who are taking any dose of Azathioprine (AZA), 6-mercaptopurine(6 MP) or